Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Burcon Nutrascience (TSE:BU)
TSX:BU
Holding TSE:BU?
Track your performance easily
BU Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.08 - C$0.29
Previous CloseC$0.08
Volume144.10K
Average Volume (3M)161.06K
Market Cap
C$22.82M
Enterprise ValueC$28.58M
Total Cash (Recent Filing)C$1.04M
Total Debt (Recent Filing)C$6.80M
Price to Earnings (P/E)―
Beta-0.22
Next Earnings
Feb 18, 2025EPS Estimate
>-C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding142,628,096
10 Day Avg. Volume268,747
30 Day Avg. Volume161,061
Standard Deviation0.27
R-Squared0.20
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)8.00
Price to Sales (P/S)41.18
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Burcon Nutrascience News
PremiumCompany Announcements
Burcon NutraScience Expands Shareholder Rights Offering
PremiumCompany Announcements
Burcon Strengthens Patent Portfolio with New Grants
PremiumCompany Announcements
Burcon Unveils Advanced Pea Protein SolutionPremiumCompany Announcements
Burcon Joins Puratos to Innovate Canola Protein Use
PremiumCompany Announcements
Burcon Expands with New Protein Facility Partnership
PremiumCompany Announcements
Burcon NutraScience Expands in Plant-Based Protein MarketPremiumCompany Announcements
Burcon Enhances Plant-Based Protein CapabilitiesPremiumCompany Announcements
Burcon NutraScience to Discuss Q2 Financials and StrategyOptions Prices
Currently, No data available
---
Ownership Overview
BU FAQ
What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was C$0.07 and its highest was C$0.29 in the past 12 months.
What is Burcon Nutrascience’s market cap?
Currently, no data Available
When is Burcon Nutrascience’s upcoming earnings report date?
Burcon Nutrascience’s upcoming earnings report date is Feb 18, 2025 which is in 58 days.
How were Burcon Nutrascience’s earnings last quarter?
Burcon Nutrascience released its earnings results on Nov 14, 2024. The company reported -C$0.017 earnings per share for the quarter, missing the consensus estimate of -C$0.008 by -C$0.009.
Is Burcon Nutrascience overvalued?
According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued.
Does Burcon Nutrascience pay dividends?
Burcon Nutrascience does not currently pay dividends.
What is Burcon Nutrascience’s EPS estimate?
Burcon Nutrascience’s EPS estimate is >-C$0.01.
How many shares outstanding does Burcon Nutrascience have?
Burcon Nutrascience has 285,256,200 shares outstanding.
What happened to Burcon Nutrascience’s price movement after its last earnings report?
Burcon Nutrascience reported an EPS of -C$0.017 in its last earnings report, missing expectations of -C$0.008. Following the earnings report the stock price went up 3.478%.
Which hedge fund is a major shareholder of Burcon Nutrascience?
Currently, no hedge funds are holding shares in TSE:BU
---
Burcon Nutrascience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.42%
12-Months-Change
Fundamentals
Return on Equity
-266.13%
Trailing 12-Months
Asset Growth
-7.57%
Trailing 12-Months
Company Description
Burcon Nutrascience
Burcon NutraScience Corp. engages in the development of valuable plant-based proteins. It also develops a portfolio of composition, application, and process patents originating from a core protein extraction and purification technology. The firm's products include CLARISOY, Peazazz, Canola proteins, and Cannabis. Burcon NutraScience was founded on November 3, 1998 and is headquartered in Vancouver, Canada.
---
BU Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a transformative strategy with an innovative business model and strong market demand, but historical challenges and recent financial metrics raise concerns.Read More>---
Technical Analysis
---